Standout Papers
Citation Impact
Citing Papers
Implantable Cardioverter-Defibrillators in Tetralogy of Fallot
2008
Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
2013
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure
2006
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Cardiomyopathy, familial dilated
2006
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Withdrawing Implantable Defibrillator Shock Therapy in Terminally Ill Patients
2006
Survival in octogenarians receiving implantable defibrillators
2006
The global burden of diabetic foot disease
2005 Standout
Catheter ablation of electrical storm
2011
Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more
2006
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Diabetic retinopathy
2010 Standout
Nonischemic Mitral Regurgitation: Prognostic Value of Nonsustained Ventricular Tachycardia after Mitral Valve Surgery
2013
The Costs of Diabetes‐related Lower Extremity Amputations in the Netherlands
1995
Survival After Application of Automatic External Defibrillators Before Arrival of the Emergency Medical System
2010
What is the “Optimal” follow-up schedule for ICD patients?
2005
Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator
2010
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
1999 StandoutNature
Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America
2008
Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure
2006
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
2013 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications
2015
Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients
2008
Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol
2005
ACCF/AHA New Insights Into the Methodology of Performance Measurement
2010
Experiences of Driving and Driving Restrictions in Recipients With an Implantable Cardioverter Defibrillator-The Patient Perspective
2010
Age‐Specific Differences in Women with Implantable Cardioverter Defibrillators: An International Multi Center Study
2008
ICD Implantation and Arrhythmia‐Free Survival in Patients with Depressed LV Function Following Surgery for Valvular Heart Disease
2008
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
2013
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: Study rationale and design
2007
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Abdominal aortic aneurysm
2005 Standout
The Managed Ventricular Pacing™ Versus VVI 40 Pacing (MVP) Trial: Clinical Background, Rationale, Design, and Implementation
2006
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Dilated cardiomyopathy
2010
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Noninvasive Risk Assessment Early After a Myocardial Infarction
2007
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
2011
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload
1999
Prognosis of Abdominal Aortic Aneurysms
1989
The Use of Angioplasty, Bypass Surgery, and Amputation in the Management of Peripheral Vascular Disease
1991
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?
2006
American Heart Association Report on the Public Access Defibrillation Conference December 8-10, 1994
1995
Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction
2013
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
2010
Implantable Cardioverter Defibrillators in Patients with Valvular Cardiomyopathy
2012
B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias
2014
Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: A meta-analysis of >35,000 patients
2014
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
2009
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
2009
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
2008
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy
2012
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
2013
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation
2007
Review of the Registry’s First Year, Data Collected, and Future Plans
2007
Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies
2007
Prevention of Heart Failure
2008
Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial
2011
Myocarditis
2011 Standout
Outcomes of Rapid Defibrillation by Security Officers after Cardiac Arrest in Casinos
2000 Standout
Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators
2010
The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis
2012
Clinical experience with a novel subcutaneous implantable defibrillator system in a single center
2011
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
The Role of the Wearable Cardioverter Defibrillator in Clinical Practice
2014
Limb-salvage angioplasty in vascular surgery practice
2005
Implantable Cardioverter-Defibrillator Shocks
2013
Diabetic foot ulcers
2003 Standout
Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome
2007
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
2009
Sickle-cell disease
2010 Standout
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
2006
Aggregate National Experience With the Wearable Cardioverter-Defibrillator
2010
Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator
2010
The Entirely Subcutaneous Implantable Cardioverter-Defibrillator
2012
Initial Clinical Experience with a New Small Sized Third‐Generation Implantable Cardioverter Defibrillator: Results of a Multicenter Study
1997
Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management
2014
Cardiogenic and Aortogenic Brain Embolism
2008
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea
2005
Heart failure
2005
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Usefulness of Sleep-Disordered Breathing to Predict Occurrence of Appropriate and Inappropriate Implantable-Cardioverter Defibrillator Therapy in Patients With Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death
2013
Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone
2014
Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT)
2008
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
2013
Endoluminal Stent–Grafts for Infrarenal Abdominal Aortic Aneurysms
1997 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Shock Anxiety among Implantable Cardioverter Defibrillator Recipients with Recent Tachyarrhythmia
2012
Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators
2007
Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly
2012
Comparison of Benefit and Mortality of Implantable Cardioverter–Defibrillator Therapy in Patients Aged ≥75 Years Versus Those <75 Years
2011
Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
2006
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: The Karolinska approach
2007
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
2005
Pediatric ICD utilization in the United States from 1997 to 2006
2010
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial
2010
Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
2005
Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention
2011
Pulsatile Stretch and Shear Stress: Physical Stimuli Determining the Production of Endothelium-Derived Relaxing Factors
1998
Selecting Patients for Discussion of the ICD as Primary Prevention for Sudden Death in Heart Failure
2006
Wearable defibrillator use in heart failure (WIF): results of a prospective registry
2012
Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: A multicenter case-control study
2012
Expansion of Heart Failure Device Therapy Into a Rural Indigent Population in Louisiana: Potential Economic and Health Policy Implications
2006
Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy
2008
Frequency of Cardiac Death in Children With Idiopathic Dilated Cardiomyopathy
2009
Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”
2007
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
2005
Complications Associated With Implantable Cardioverter-Defibrillator Replacement in Response to Device Advisories
2006
Gender differences in arrhythmias
2002
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Defibrillator Implantation Early after Myocardial Infarction
2009
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
2008
Management of atrial fibrillation in patients with heart failure
2006
Sudden Cardiac Death Risk Stratification in Patients With Nonischemic Dilated Cardiomyopathy
2014
A Pilot Study Examining the Performance of Polynomial‐Modeled Ventricular Shock Electrograms for Rhythm Discrimination in Implantable Devices
2006
Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy: A population-based study, 1971–1987
1989
Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease
2007
Ventricular Tachyarrhythmias and Mortality in Patients With an Implantable Cardioverter Defibrillator
2013
The Yeast Tor Signaling Pathway Is Involved in G2/M Transition via Polo-Kinase
2008 StandoutNobel
Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction
2013
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
Risk stratification for sudden cardiac death: current status and challenges for the future
2014
Myocarditis
2009 Standout
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator
2015
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies
2015
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008
2009
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
2010
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
2005 Standout
Long-Term Outcomes of Dilated Cardiomyopathy Diagnosed During Childhood
2013
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Sudden Cardiac Death in Adult Congenital Heart Disease
2012
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families
2012
Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
2010
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease
2011
Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold
2006
Management of Recalled Pacemakers and Implantable Cardioverter-Defibrillators
2006
Acute Myocardial Infarction in Women
2016
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 Decades
2013
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Pacemaker and ICD Generator Malfunctions
2006
Wearable Cardioverter-Defibrillators
2013
Incidence and Predictors of Sudden Cardiac Arrest in Adults With Congenital Heart Defects Repaired Before Adult Life
2012
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias
2013
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients
2005
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)
2011
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention
2009
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias
2007
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction
2013
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Quality of Life and Psychological Status of Patients With Implantable Cardioverter Defibrillators
2006
Contemporary Pacemaker and Defibrillator Device Therapy
2007
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
2009
The Year in Heart Failure 2005
2006
Pathological Ventricular Remodeling
2013
HFSA 2010 Comprehensive Heart Failure Practice Guideline
2010
Epidemiology and Genetics of Sudden Cardiac Death
2012
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
2008
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis
2006
The morphogenesis checkpoint: how yeast cells watch their figures
2003
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Artery Injury Due to Catheter Ablation in Adults
2009
Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor—2
2001
Transthoracic Cardioversion of Atrial Fibrillation
2000
ACCF/AHA New Insights Into the Methodology of Performance Measurement
2010
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
2006
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
Long-Term Arrhythmia-Free Survival in Patients With Severe Left Ventricular Dysfunction and No Inducible Ventricular Tachycardia After Myocardial Infarction
2014
Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention – is it necessary?
2014
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients
2009
Works of George Johnson being referenced
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure
2009
Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: Implications for management and future system design
1995
Developments, complications and limitations of catheter-mediated electrical ablation of posterior accessory atrioventricular pathways
1988
Home Use of Automated External Defibrillators for Sudden Cardiac Arrest
2008
Malignant Sustained Ventricular Tachyarrhythmias in Women:
1997
Serial Defibrillation Threshold Measures in Man: A Prospective Controlled Study
1995
Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure
2008
A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans
1989
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial
2008
Prospective comparison of sequential pulse and single pulse defibrillation with use of two different clinically available systems
1989
SCD-HEFT: NON-SUSTAINED VENTRICULAR TACHYCARDIA ON BASELINE HOLTER MONITOR ASSOCIATION WITH OVERALL MORTALITY
2011
Mechanical stress stimulates aortic endothelial cells to proliferate
1987
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure
2006
Lower extremity amputation: The control series
1986
Vascular surgery in the United States
1987
Truncated Biphasic Pulses for Transthoracic Defibrillation
1995
Long-term Follow-up in the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT)
2012
Lower extremity amputation: the control series.
1986
AB24-2
2006
Risk of Thromboembolism in Heart Failure
2007
Vascular surgery in the United States
1987
No Benefit From Defibrillation Threshold Testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
2008